These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10450269)

  • 1. Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
    Farren CK; O'Malley SS
    Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Depression in alcohol addicted patients].
    Ponizovskiy PA; Gofman AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    Kranzler HR; Van Kirk J
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acamprosate and naltrexone: similar efficacy for relapse].
    Saitz R
    Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
    [No Abstract]   [Full Text] [Related]  

  • 6. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
    Neumeister A; Winkler A; Wöber-Bingöl C
    Am J Psychiatry; 1999 May; 156(5):797. PubMed ID: 10327921
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications to treat alcoholism.
    Johnson BA; Ait-Daoud N
    Alcohol Res Health; 1999; 23(2):99-106. PubMed ID: 10890803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternatives to naltrexone in animal models.
    Overstreet DH
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):231A-235A. PubMed ID: 8947271
    [No Abstract]   [Full Text] [Related]  

  • 15. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the adoption of medications for alcohol dependence.
    Ducharme LJ; Knudsen HK; Roman PM
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S13-9. PubMed ID: 17114950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].
    Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A
    Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs against alcohol abuse].
    Mørland J
    Tidsskr Nor Laegeforen; 2006 Dec; 126(24):3268-9. PubMed ID: 17170774
    [No Abstract]   [Full Text] [Related]  

  • 20. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
    Roos CR; Mann K; Witkiewitz K
    Addict Biol; 2017 Nov; 22(6):1528-1539. PubMed ID: 27480445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.